Memantine and reduced time with dyskinesia in Parkinson's Disease.
Research output: Contribution to journal › Article
The partial glutamate antagonist amantadine is currently used in clinical practice, to reduce dyskinesia developing as a side-effect of levodopa treatment in patients suffering from Parkinson's disease (PD). This study was aimed at evaluating the antidyskinetic effect of another glutamate antagonist, memantine.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Journal||Acta Neurologica Scandinavica|
|Early online date||2015 Aug 3|
|Publication status||Published - 2015|